Sheel Biotech IPO is a Book Building IPO listing on NSE EMERGE exchange, with an ipo size of ₹ 34.02 Cr. The company is based in New Delhi and caters to Agro sector. Narnolia Financial Services is the merchant banker of Sheel Biotech IPO. It is a SME IPO which filed its Draft Red Herring Prospectus (DRHP) on 27th November 2024. Sheel Biotech IPO open date is 30th September 2025 and close date is 3rd October 2025. IPO Allotment Date is 6th October 2025 and Listing date is 8th October 2025.
Sheel Biotech IPO size is ₹ 34.02 Cr. with IPO price of ₹ 63.00. IPO subscription will start on IPO open date and end on IPO close date as per above. IPO valuation metrics can be seen here.
Particulars | Amount |
---|---|
To meet the Capital Expenditure requirements | 9.11 |
To meet out the expenses for Working capital requirement | 15.88 |
To meet out the expenses for General Corporate Purpose | [●] |
Narnolia Financial Services Limited is the book-running lead manager of the Sheel Biotech IPO. Skyline Financial Services Private Limited is the Registrar and Market Maker is Mansi Share & Stock Broking Private Limited for Sheel Biotech IPO.
Sheel Biotech IPO anchor investors are the below investors. The number of anchor investors in this IPO is 5.
Anchor Investor Name | No. of shares Allotted | Offer Price (in ₹.) | Amount Invested (in ₹.) |
---|---|---|---|
Bharat Venture Opportunities | 634,000.00 | ₹ 63.00 | ₹ 39,942,000.00 |
Aarth AIF | 410,000.00 | ₹ 63.00 | ₹ 25,830,000.00 |
Saint Capital Fund | 160,000.00 | ₹ 63.00 | ₹ 10,080,000.00 |
Vbcube Ventures Fund | 160,000.00 | ₹ 63.00 | ₹ 10,080,000.00 |
Sanshi Fund-I | 160,000.00 | ₹ 63.00 | ₹ 10,080,000.00 |
Sheel Biotech IPO Draft red herring prospectus (DRHP) and Red Herring prospectus (RHP) are available below.
Sheel Biotech IPO, based in New Delhi, operates in the Agro sector with a focus on Business of growing, developing, processing, and supplying a wide range of plants for field crops, fruits, vegetables, and ornamental plants. The company is launching its SME IPO on the NSE EMERGE exchange, using the Book Building Issue method. Sheel Biotech IPO size is ₹ 34.02 Cr. with fresh issue size of ₹ 34 Cr. and Offer for sale being ₹ Nil
The IPO allotment date for Sheel Biotech IPO is expected to be 6th October 2025, after the finalization of basis of allotment. Investors can check Sheel Biotech IPO allotment status on the registrars website, Skyline Financial Services Private Limited . Sheel Biotech IPO refund dates are 7th October 2025.
Sheel Biotech IPO is expected to be listed on 8th October 2025.
The upper price band for the Sheel Biotech IPO is set at ₹ 63.00 per equity share. IPO price band is arrived at on the basis of IPO Valuation (P/E multiple) which is mentioned in the RHP.
For IPO analysis on Sheel Biotech IPO, explore our Financial Review Page for insights on fundamentals, peer analysis, and key IPO data, assisting investors to make informed decisions to apply or not.
To apply for the Sheel Biotech IPO, investors can use the ASBA (Application Supported by Blocked Amount) process via their bank's net banking or apply through UPI using a registered broker or trading app. The IPO is available in retail, HNI, and institutional investor categories. Investors must select the lot size, enter bid details within the price band, and submit their application before the IPO closing date of 3rd October 2025. After submission, funds are blocked until the basis of allotment of Sheel Biotech IPO is finalised.
The merchant banker for Sheel Biotech IPO is Narnolia Financial Services Limited . Narnolia Financial Services Limited manages the IPO process, including underwriting, regulatory compliance, and investor coordination. Investors can refer to the Sheel Biotech IPO RHP for further details.
The registrar for Sheel Biotech IPO is Skyline Financial Services Private Limited . Investors can go to Skyline Financial Services Private Limited registrar website for IPO allotment status, refund processing, and other queries related to Sheel Biotech IPO through their official website or helpline.
Sheel Biotech IPO was subscribed 15.97 times. Stay updated on IPO details, subscription, and allotment news for informed investment decisions.
Sheel Biotech IPO may offer opportunites, depending on your investment strategy. For in-depth analysis, risk factors, and KPIs, check our detailed report on Sheel Biotech Financial Review Page
Merchant Banker(s) of Sheel Biotech IPO: Narnolia Financial Services Limited
Sheel Biotech IPO subscription was 15.97 X. IPO subscription refers to applications received in an IPO by each quota, i.e., QIB, Retail, and NII. In some IPOs, Eligible employee quota and shareholder’s quota are also present. Learn more about IPO subscriptions here.
Sheel Biotech IPO listed at a listing price of 91.00 against the offer price of 63.00.
The current market price of Sheel Biotech is 95.55.
Why Us?